Cancer
Keeping you updated with all the latest developments, researches, drug trials and treatment protocols for cancer. For detailed information about cancer including cancer types, cancer treatments, cancer drugs, cancer care and also the best cancer hospitals and cancer doctors in Thailand, please visit our other website: www.thailandcancerhelp.com
Presented by
Source: George Washington University  Mar 17, 2019
Researchers at the George Washington University (GW) Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications. "With this study, we validate the role of USP15 in maintaining genome stability and tumor suppression and inform novel treatments for breast cancer," said H...
Source: American Society for Biochemistry and Molecular Biology  Mar 16, 2019
Fewer than half of ovarian cancer patients survive until five years after diagnosis. According to the American Cancer Society, this is because only about one-fifth of ovarian cancer cases are detected early, when the chances of successful treatment and recovery are highest.   "If we could change this reality by detecting ovarian cancer at a curable stage, we could save many lives,"...
Source: Columbia University, Irving Medical Center   Mar 10, 2019
Researchers at the Columbia University College of Dental Medicine have determined how F. nucleatum-- a common oral bacteria often implicated in tooth decay -- accelerates the growth of colon cancer.  The findings could make it easier to identify and treat more aggressive colon cancers. It also helps explain why some cases advance far more quickly than others, thanks to the same bacter...
Source: Institute of Cancer Research, London  Mar 10, 2019
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals. Scientists found that PARP inhibitors sparked a powerful immune response when used against cancer cells with weaknesses in repairing their DNA.   The study changes our understanding of how PARP inhibit...
Source: NRG Oncology, Pennsylvania  Feb 17, 2019
The NRG Oncology clinical study NRG-RTOG 0415 determined that a hypofractionated radiotherapy schedule (H-RT), a treatment schedule that delivers a total dose of radiotherapy over a shorter period of time, is not worse than the conventional radiotherapy schedule (C-RT) in terms of bowel, bladder, sexual, and general quality of life (QOL) as well as anxiety and depression for men with low risk pros...